IN8BIO, INC. 8-K

What Happened IN8bio, Inc. (INAB) filed an 8-K (Item 5.02) reporting that director Alan S. Roemer notified the Board on February 26, 2026 that he will resign as a director and as a member of the Audit and Compensation Committees, effective February 28, 2026. The filing states Mr. Roemer’s decision was not due to any disagreement with the company, its management, the Board or any committee. The Board has appointed independent director Jeremy Graff as Interim Chair of the Board, effective February 28, 2026.

Key Details

• Filing: Form 8-K (Item 5.02) dated February 27, 2026.
• Resignation notice: Alan S. Roemer notified the Board on Feb 26, 2026; resignation effective Feb 28, 2026.
• Committee roles: Mr. Roemer resigned from the Audit and Compensation Committees.
• Board leadership: Jeremy Graff (independent director) appointed Interim Chair effective Feb 28, 2026.

Why It Matters Board composition and leadership affect corporate governance and oversight — important considerations for investors evaluating management accountability and strategic direction. This filing documents a clean, non-disagreement resignation and an immediate interim chair appointment, meaning continuity of board leadership. Investors should note the change but the company did not report any disputes or operational issues tied to the departure.